Experts and Doctors on vascular diseases in Ann Arbor, Michigan, United States


Locale: Ann Arbor, Michigan, United States
Topic: vascular diseases

Top Publications

  1. Hasegawa T, Iwanaga K, Hultquist D, Liao H, Visovatti S, Pinsky D. Suppression of nitrosative and oxidative stress to reduce cardiac allograft vasculopathy. Am J Physiol Heart Circ Physiol. 2009;296:H1007-16 pubmed publisher
    ..Collectively, antioxidant administration during the initial 3 days after transplantation significantly reduces nitrosative and oxidative stress in cardiac allografts, modulates immune responses, and protects against vasculopathy. ..
  2. Moore R, Hawley A, Sigler R, Farris D, Wrobleski S, Ramacciotti E, et al. Tissue inhibitor of metalloproteinase-1 is an early marker of acute endothelial dysfunction in a rodent model of venous oxidative injury. Ann Vasc Surg. 2009;23:498-505 pubmed publisher
    ..Our results support the hypothesis that increased expression of TIMP-1 in venous endothelium and plasma may serve as an early indicator of endothelial dysfunction. ..
  3. Lucas D. Angiosarcoma, radiation-associated angiosarcoma, and atypical vascular lesion. Arch Pathol Lab Med. 2009;133:1804-9 pubmed publisher
    ..Recently, vascular-type atypical vascular lesion, which resembles hemangioma, has been described, thus expanding the definition of this entity. ..
  4. Barnes G, Gafoor S, Wakefield T, Upchurch G, Henke P, Froehlich J. National trends in venous disease. J Vasc Surg. 2010;51:1467-73 pubmed publisher
    ..Many of these patients are being seen by PCPs who may require additional training and infrastructure for appropriate patient care. ..
  5. Mann J, Lam R, Weng S, Sun Y, Fu J. A silicone-based stretchable micropost array membrane for monitoring live-cell subcellular cytoskeletal response. Lab Chip. 2012;12:731-40 pubmed publisher
    ..Our mPAM device and live-cell subcellular contractile measurements will help elucidate the mechanotransductive system in VSMCs and thus contribute to our understanding of pressure-induced vascular disease processes. ..
  6. Wang H, Luo W, Wang J, Guo C, Wang X, Wolffe S, et al. Obesity-induced endothelial dysfunction is prevented by deficiency of P-selectin glycoprotein ligand-1. Diabetes. 2012;61:3219-27 pubmed publisher
    ..Psgl-1 inhibition may be a useful treatment strategy for targeting vascular disease associated with obesity. ..
  7. Guest A, Cohan R, Korobkin M, Platt J, Bundschu C, Francis I, et al. Assessment of the clinical utility of the rim and comet-tail signs in differentiating ureteral stones from phleboliths. AJR Am J Roentgenol. 2001;177:1285-91 pubmed
  8. Park J, Whitesall S, D Alecy L, Shu L, Shayman J. Vascular dysfunction in the alpha-galactosidase A-knockout mouse is an endothelial cell-, plasma membrane-based defect. Clin Exp Pharmacol Physiol. 2008;35:1156-63 pubmed publisher
    ..These results suggest that the vasculopathy associated with Fabry disease is localized to the endothelium, despite the accumulation of GSLs throughout the vasculature. ..
  9. Ohman M, Eitzman D. Targeting MCP-1 to reduce vascular complications of obesity. Recent Pat Cardiovasc Drug Discov. 2009;4:164-76 pubmed
    ..Since MCP-1 promotes atherosclerosis, inhibition of MCP-1 may be effective in reducing the vascular risk associated with obesity. ..

More Information


  1. Huang H, Xie C, Sun X, Ritchie R, Zhang J, Chen Y. miR-10a contributes to retinoid acid-induced smooth muscle cell differentiation. J Biol Chem. 2010;285:9383-9 pubmed publisher
    ..These studies suggest that miR-10a may play important roles in vascular biology and have implications for the diagnosis and treatment of vascular diseases. ..
  2. Levine D, Langa K. Vascular cognitive impairment: disease mechanisms and therapeutic implications. Neurotherapeutics. 2011;8:361-73 pubmed publisher
    ..Given its growing health, social, and economic burden, the prevention and treatment of VCI are critical priorities for clinical care and research. ..
  3. Heider A. Fetal Vascular Malperfusion. Arch Pathol Lab Med. 2017;141:1484-1489 pubmed publisher
    ..Fetal vascular malperfusion, also known as fetal thrombotic vasculopathy, remains an underrecognized pathologic finding and should be noted during placental evaluation...